Company Overview
E-health and genomics solution
Company History
54gene was founded in 2018. Public founder information in the source set points to Abasi Ene-Obong, Ogochukwu Francis Osifo, Gatumi Aliyu. Its latest captured funding/news event in the source set was in 2021, recorded as Series B.
Key Facts
| Country | Nigeria |
| Founded | 2018 |
| Founders | Abasi Ene-Obong, Ogochukwu Francis Osifo, Gatumi Aliyu |
| Sector | Healthcare |
| Operational Status | Closed |
| Latest Round | Series B, 2021, $25M |
| Total Disclosed Funding | $45M |
| Website | https://www.54gene.com/ |
Business Model
54gene appears to operate a product-led business model in the Healthcare sector. Based on public descriptions, it generates value through technology-enabled services, software, marketplace access, operations, or financial infrastructure.
Products and Services
- Pharmaceutical or care infrastructure
- Hospital or provider digitisation
- Supply-chain services
- Patient access tools
Funding and Market Position
Public deal records in the source set show 4 disclosed funding event(s), with about $45M captured in total. The most recent event is recorded as Series B, 2021, $25M.
Contact Information
The most reliable public contact channel in the source set is the official website: https://www.54gene.com/. Public phone numbers and public support emails were not consistently available at scale, so the website/contact form is the best public route.
Company Location
Operational Status
Winding down operations reported in 2023; legal disputes over asset sale continued in 2025. Status recorded here is a best-effort assessment as of March 21, 2026.
Why This Startup Matters
As a Nigerian startup in the Healthcare space, 54gene matters because it addresses local market problems with a scalable digital product or operational model.
Sources
Related Startups
- RxAll
- Platos Health
- Myltura